PRECISION BIOSCIENCES INC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PRECISION BIOSCIENCES INC (DTIL) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.84 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.84M, a 37.21% decline year-over-year.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.55M, a 45.11% decline year-over-year.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.39M, a 25.41% decline year-over-year.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $2.94M, a 0.31% increase year-over-year.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $10.19M, a 19.18% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $12.60M, a 10.23% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $14.04M, a 26.86% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $19.20M, a 16.25% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.84M 10-Q · filed 2026-08-06 | $3.39M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.55M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $10.19M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $2.39M 10-Q · filed 2025-11-03 | $5.32M derived: sum of 2 quarters · filed 2026-08-06 | $8.14M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $2.94M 10-Q · filed 2026-08-06 | $5.76M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.82M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $12.60M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $3.20M 10-Q · filed 2025-11-03 | $6.13M derived: sum of 2 quarters · filed 2025-11-03 | $9.03M derived: sum of 3 quarters · filed 2025-11-03 | |
| 2024-06-30 | $2.93M 10-Q · filed 2025-11-03 | $5.83M derived: sum of 2 quarters · filed 2025-11-03 | ||
| 2024-03-31 | $2.91M 10-Q · filed 2025-11-03 | |||
| 2023-12-31 | $14.04M 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $3.10M 10-Q · filed 2024-11-04 | $6.98M derived: sum of 2 quarters · filed 2024-11-04 | $11.07M derived: sum of 3 quarters · filed 2024-11-04 | |
| 2023-06-30 | $3.87M 10-Q · filed 2024-11-04 | $7.97M derived: sum of 2 quarters · filed 2024-11-04 | ||
| 2023-03-31 | $4.09M 10-Q · filed 2024-11-04 | |||
| 2022-12-31 | $19.20M 10-K · filed 2024-03-27 | |||
| 2022-09-30 | $5.13M 10-Q · filed 2023-11-07 | $10.27M derived: sum of 2 quarters · filed 2023-11-07 | $14.66M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $5.14M 10-Q · filed 2023-11-07 | $9.53M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | $4.39M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $16.51M 10-K · filed 2023-03-09 | |||
| 2021-09-30 | $4.55M 10-Q · filed 2022-11-08 | $8.45M derived: sum of 2 quarters · filed 2022-11-08 | $12.08M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $3.90M 10-Q · filed 2022-11-08 | $7.53M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $3.63M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $13.79M 10-K · filed 2022-03-15 | |||
| 2020-09-30 | $3.71M 10-Q · filed 2021-11-10 | $6.83M derived: sum of 2 quarters · filed 2021-11-10 | $9.93M derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-06-30 | $3.12M 10-Q · filed 2021-11-10 | $6.22M derived: sum of 2 quarters · filed 2021-11-10 | ||
| 2020-03-31 | $3.10M 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $8.94M 10-K · filed 2021-03-18 | |||
| 2019-09-30 | $2.49M 10-Q · filed 2020-11-10 | $4.77M derived: sum of 2 quarters · filed 2020-11-10 | $6.32M derived: sum of 3 quarters · filed 2020-11-10 | |
| 2019-06-30 | $2.28M 10-Q · filed 2020-11-10 | $3.83M derived: sum of 2 quarters · filed 2020-11-10 | ||
| 2019-03-31 | $1.55M 10-Q · filed 2020-11-10 | |||
| 2018-12-31 | $2.45M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $292.00K 10-Q · filed 2019-11-12 | $546.00K derived: sum of 2 quarters · filed 2019-11-12 | $697.00K derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-06-30 | $254.00K 10-Q · filed 2019-11-12 | $405.00K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-03-31 | $151.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |